Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009474429> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W3009474429 endingPage "1642" @default.
- W3009474429 startingPage "1639" @default.
- W3009474429 abstract "BACKGROUND Allergic transfusion reactions (ATRs) are a common adverse reaction to transfusion therapy and can be potentially fatal. Washing blood products is the most effective strategy for preventing ATRs; however, washed products, especially platelets, are not available at many blood centers. STUDY DESIGN AND METHODS A 29‐year‐old female patient with an advanced myelodysplastic/myeloproliferative neoplasm, unclassifiable, developed severe ATRs after four platelet transfusions in a week. She showed no response to premedication with histamines and steroids and still had severe ATRs with the next three platelet transfusions. A laboratory workup revealed that her IgA level was slightly decreased, while her haptoglobin level was normal. Anti‐IgA testing was not available. The patient decided to undergo allogeneic peripheral blood stem cell (PBSC) transplantation. As the onset of symptoms ATR, which were similar to Type 1 hypersensitivity reactions mediated by IgE antibodies, occurred immediately after transfusion and omalizumab is a humanized monoclonal anti‐IgE, we elected to offer off‐label use of omalizumab before administering the conditioning regimen. RESULTS Omalizumab was injected subcutaneously at a dose of 150 mg. Surprisingly, transfusion reactions fully resolved within 24 hours. No serious side effects were noticed. Another 150 mg of omalizumab was administered 1 day before PBSC infusion. The patient remained asymptomatic without any signs of ATRs throughout the whole period of transplantation. Seven months after transplantation, the patient was in complete remission without overt complications. CONCLUSION This case suggests that omalizumab is a promising new alternative treatment for the prevention of severe ATRs." @default.
- W3009474429 created "2020-03-13" @default.
- W3009474429 creator A5006739024 @default.
- W3009474429 creator A5018863416 @default.
- W3009474429 creator A5045197865 @default.
- W3009474429 creator A5046268632 @default.
- W3009474429 creator A5073536906 @default.
- W3009474429 creator A5088549603 @default.
- W3009474429 date "2020-03-05" @default.
- W3009474429 modified "2023-10-16" @default.
- W3009474429 title "Successful prevention of severe allergic transfusion reactions with omalizumab" @default.
- W3009474429 cites W1656622090 @default.
- W3009474429 cites W1666649732 @default.
- W3009474429 cites W1976965772 @default.
- W3009474429 cites W2028573353 @default.
- W3009474429 cites W2047215271 @default.
- W3009474429 cites W2048310526 @default.
- W3009474429 cites W2061452912 @default.
- W3009474429 cites W2078408849 @default.
- W3009474429 cites W2088215603 @default.
- W3009474429 cites W2111006543 @default.
- W3009474429 cites W2151196835 @default.
- W3009474429 cites W2632601572 @default.
- W3009474429 cites W2726559579 @default.
- W3009474429 cites W2783778288 @default.
- W3009474429 cites W2916695386 @default.
- W3009474429 cites W2976053572 @default.
- W3009474429 doi "https://doi.org/10.1111/trf.15735" @default.
- W3009474429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32134497" @default.
- W3009474429 hasPublicationYear "2020" @default.
- W3009474429 type Work @default.
- W3009474429 sameAs 3009474429 @default.
- W3009474429 citedByCount "3" @default.
- W3009474429 countsByYear W30094744292021 @default.
- W3009474429 countsByYear W30094744292022 @default.
- W3009474429 crossrefType "journal-article" @default.
- W3009474429 hasAuthorship W3009474429A5006739024 @default.
- W3009474429 hasAuthorship W3009474429A5018863416 @default.
- W3009474429 hasAuthorship W3009474429A5045197865 @default.
- W3009474429 hasAuthorship W3009474429A5046268632 @default.
- W3009474429 hasAuthorship W3009474429A5073536906 @default.
- W3009474429 hasAuthorship W3009474429A5088549603 @default.
- W3009474429 hasConcept C126322002 @default.
- W3009474429 hasConcept C141071460 @default.
- W3009474429 hasConcept C141105273 @default.
- W3009474429 hasConcept C159654299 @default.
- W3009474429 hasConcept C197934379 @default.
- W3009474429 hasConcept C203014093 @default.
- W3009474429 hasConcept C207480886 @default.
- W3009474429 hasConcept C2775933838 @default.
- W3009474429 hasConcept C2777910003 @default.
- W3009474429 hasConcept C2778300832 @default.
- W3009474429 hasConcept C2778564945 @default.
- W3009474429 hasConcept C2911091166 @default.
- W3009474429 hasConcept C71924100 @default.
- W3009474429 hasConceptScore W3009474429C126322002 @default.
- W3009474429 hasConceptScore W3009474429C141071460 @default.
- W3009474429 hasConceptScore W3009474429C141105273 @default.
- W3009474429 hasConceptScore W3009474429C159654299 @default.
- W3009474429 hasConceptScore W3009474429C197934379 @default.
- W3009474429 hasConceptScore W3009474429C203014093 @default.
- W3009474429 hasConceptScore W3009474429C207480886 @default.
- W3009474429 hasConceptScore W3009474429C2775933838 @default.
- W3009474429 hasConceptScore W3009474429C2777910003 @default.
- W3009474429 hasConceptScore W3009474429C2778300832 @default.
- W3009474429 hasConceptScore W3009474429C2778564945 @default.
- W3009474429 hasConceptScore W3009474429C2911091166 @default.
- W3009474429 hasConceptScore W3009474429C71924100 @default.
- W3009474429 hasFunder F4320321001 @default.
- W3009474429 hasIssue "7" @default.
- W3009474429 hasLocation W30094744291 @default.
- W3009474429 hasOpenAccess W3009474429 @default.
- W3009474429 hasPrimaryLocation W30094744291 @default.
- W3009474429 hasRelatedWork W1207784773 @default.
- W3009474429 hasRelatedWork W12465354 @default.
- W3009474429 hasRelatedWork W1571696686 @default.
- W3009474429 hasRelatedWork W1978006696 @default.
- W3009474429 hasRelatedWork W2015379751 @default.
- W3009474429 hasRelatedWork W2085552858 @default.
- W3009474429 hasRelatedWork W2101202640 @default.
- W3009474429 hasRelatedWork W2561511743 @default.
- W3009474429 hasRelatedWork W2884978230 @default.
- W3009474429 hasRelatedWork W3009751573 @default.
- W3009474429 hasVolume "60" @default.
- W3009474429 isParatext "false" @default.
- W3009474429 isRetracted "false" @default.
- W3009474429 magId "3009474429" @default.
- W3009474429 workType "article" @default.